Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allenbach

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
NAR Molecular Medicine|May 27, 2026
Defective plasticity in dermatomyositis patients muscle stem cells is associated with sustained intrinsic inflammatory signaling and disruption of the histone H3.3 chromatin loading pathwayWilhelm Bouchereau, Linda Chenane, Michèle Weiss-Gayet, et al.
Circulation|October 26, 2018
Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy RevolutionCéline Anquetil, Joe-Elie Salem, Bénédicte Lebrun-Vignes, et al.
Rheumatology (Oxford, England)|August 12, 2025
Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two casesLoraine Combemale, Alexandre-Raphael Wery, Gérôme Bohelay, et al.
Archives of Cardiovascular Diseases|February 5, 2022
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditisStéphane Ederhy, Perrine Devos, Bruno Pinna, et al.
Annals of the Rheumatic Diseases|October 13, 2018
<i>In vivo</i> pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathyCécile Bergua, Hélène Chiavelli, Yves Allenbach, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2021
NanoString technology distinguishes anti-TIF-1γ<sup>+</sup> from anti-Mi-2<sup>+</sup> dermatomyositis patientsCorinna Preusse, Pascale Eede, Lucie Heinzeling, et al.
The Journal of Clinical Psychiatry|December 8, 2022
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter StudyVictor Pitron, Willys Cantenys, Anne Herbelin, et al.
Arthritis and Rheumatism|December 8, 2011
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritisBenjamin Terrier, Guillaume Geri, Wahiba Chaara, et al.
Brain : a Journal of Neurology|October 14, 2011
Long-term observational study of sporadic inclusion body myositisOlivier Benveniste, Marguerite Guiguet, Jane Freebody, et al.
BMC Pulmonary Medicine|February 25, 2026
AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patientsYoulia Kuzmanovic, Amira Benattia, Amandine Laporte, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
NAR Molecular Medicine|May 27, 2026
Defective plasticity in dermatomyositis patients muscle stem cells is associated with sustained intrinsic inflammatory signaling and disruption of the histone H3.3 chromatin loading pathwayWilhelm Bouchereau, Linda Chenane, Michèle Weiss-Gayet, et al.
Circulation|October 26, 2018
Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy RevolutionCéline Anquetil, Joe-Elie Salem, Bénédicte Lebrun-Vignes, et al.
Rheumatology (Oxford, England)|August 12, 2025
Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two casesLoraine Combemale, Alexandre-Raphael Wery, Gérôme Bohelay, et al.
Archives of Cardiovascular Diseases|February 5, 2022
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditisStéphane Ederhy, Perrine Devos, Bruno Pinna, et al.
Annals of the Rheumatic Diseases|October 13, 2018
<i>In vivo</i> pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathyCécile Bergua, Hélène Chiavelli, Yves Allenbach, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2021
NanoString technology distinguishes anti-TIF-1γ<sup>+</sup> from anti-Mi-2<sup>+</sup> dermatomyositis patientsCorinna Preusse, Pascale Eede, Lucie Heinzeling, et al.
The Journal of Clinical Psychiatry|December 8, 2022
Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter StudyVictor Pitron, Willys Cantenys, Anne Herbelin, et al.
Arthritis and Rheumatism|December 8, 2011
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritisBenjamin Terrier, Guillaume Geri, Wahiba Chaara, et al.
Brain : a Journal of Neurology|October 14, 2011
Long-term observational study of sporadic inclusion body myositisOlivier Benveniste, Marguerite Guiguet, Jane Freebody, et al.
BMC Pulmonary Medicine|February 25, 2026
AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patientsYoulia Kuzmanovic, Amira Benattia, Amandine Laporte, et al.
Pageof 19